Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-003529
Filing Date
2025-02-10
Accepted
2025-02-10 18:04:17
Documents
1
Period of Report
2025-02-06

Document Format Files

Seq Description Document Type Size
1 form4-02102025_110214.html 4  
1 form4-02102025_110214.xml 4 7226
  Complete submission text file 0001415889-25-003529.txt   8882
Mailing Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130 888-969-7879
Travere Therapeutics, Inc. (Issuer) CIK: 0001438533 (see all company filings)

EIN.: 262383102 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O RETROPHIN, INC. 12255 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130
Business Address
Baynes Roy D. (Reporting) CIK: 0001680739 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36257 | Film No.: 25607021